Cargando…

Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?

SIMPLE SUMMARY: Specific treatment for COVID-19 infections in cancer patients is lacking while the demand for treatment is increasing. Therefore, we explored the effect of Rintatolimod, a Toll-like receptor 3 (TLR3) agonist, on human epithelial cancerous cells. Our results demonstrated that Rintatol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mustafa, Dana A. M., Saida, Lawlaw, Latifi, Diba, Wismans, Leonoor V., de Koning, Willem, Zeneyedpour, Lona, Luider, Theo M., van den Hoogen, Bernadette, van Eijck, Casper H. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227153/ https://www.ncbi.nlm.nih.gov/pubmed/34207861 http://dx.doi.org/10.3390/cancers13122896

Ejemplares similares

Rintatolimod (Ampligen(®)) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program
por: el Haddaoui, Hassana, et al.
Publicado: (2022)

Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes
por: de Koning, Willem, et al.
Publicado: (2021)

Differential Expression of BOC, SPOCK2, and GJD3 Is Associated with Brain Metastasis of ER-Negative Breast Cancers
por: Pedrosa, Rute M. S. M., et al.
Publicado: (2021)

Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View
por: Zeneyedpour, Lona, et al.
Publicado: (2019)

Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors
por: Aziz, Hosein M., et al.
Publicado: (2023)

Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022)

Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
por: Ju, Jie, et al.
Publicado: (2021)

An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
por: Dekker, Lennard J. M., et al.
Publicado: (2010)

Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
por: Mitchell, William M
Publicado: (2016)

Looking back on the COVID-19 pandemic in an elite sports team using whole genome sequencing
por: Shamier, Marc.C., et al.
Publicado: (2023)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes
por: de Graaf, J. Fréderique, et al.
Publicado: (2022)

T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression
por: Mustafa, Dana A. M., et al.
Publicado: (2018)

Increase of mast cells in COVID‐19 pneumonia may contribute to pulmonary fibrosis and thrombosis
por: Wismans, Leonoor V, et al.
Publicado: (2022)

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients
por: de Koning, Willem, et al.
Publicado: (2023)

Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Strayer, David R., et al.
Publicado: (2020)

RNA from stabilized whole blood enables more comprehensive immune gene expression profiling compared to RNA from peripheral blood mononuclear cells
por: van der Sijde, Fleur, et al.
Publicado: (2020)

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
por: Strayer, David R., et al.
Publicado: (2012)

Identifying Molecular Changes in Early Cervical Cancer Samples of Patients That Developed Metastasis
por: de Geus, Vera, et al.
Publicado: (2022)

High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma
por: Aziz, Mohammad Hosein, et al.
Publicado: (2022)

Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
por: de Graaf, J. Fréderique, et al.
Publicado: (2022)

Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases
por: Ramanathan, Rajesh, et al.
Publicado: (2021)

Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer
por: Vietsch, Eveline E, et al.
Publicado: (2015)

A Novel Method—Amenable for High-throughput Screening Purposes—to Quantify Antiviral Activity Against Viruses that Induce Limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2011)

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer
por: van ‘t Land, Freek R., et al.
Publicado: (2022)

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
por: van der Sijde, Fleur, et al.
Publicado: (2019)

TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2
por: Venkatesan, Subramanian, et al.
Publicado: (2016)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
por: Blaauboer, Amber, et al.
Publicado: (2022)

Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer
por: Köse, Büşra, et al.
Publicado: (2023)

Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells
por: Booy, Stephanie, et al.
Publicado: (2014)

Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2013)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
por: Blaauboer, Amber, et al.
Publicado: (2020)

Dataset from a proteomics analysis of tumor antigens shared between an allogenic tumor cell lysate vaccine and pancreatic tumor tissue.
por: Stingl, C., et al.
Publicado: (2022)

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
por: Suker, Mustafa, et al.
Publicado: (2018)

Expression Sites of Colligin 2 in Glioma Blood Vessels
por: Mustafa, Dana, et al.
Publicado: (2008)

B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients
por: Vietsch, Eveline E., et al.
Publicado: (2023)

Pancreatic Duct Obstruction in a Middle-Aged Woman: A Case Report
por: Suker, Mustafa, et al.
Publicado: (2017)

A Rare Tumor in the Common Bile Duct: A Case Report
por: Suker, Mustafa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ji1juue3foig6o8qb7kuprlp8